Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
RGEN	Repligen Corp Manufacturing · Year ended 2025-12-31 · USD	$738.26M	$48.89M	6.6%	2.3%	16.4%	$0.86
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
TARS	Tarsus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$451.36M	-$66.42M	-14.7%	-19.3%	146.7%	-$1.59
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07
RGNX	REGENXBIO Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.44M	-$193.88M	-113.8%	-188.7%	104.5%	-$3.76
DNA	Ginkgo Bioworks Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.16M	-$312.76M	-183.8%	-61.5%	-25.1%	-$5.64
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a

Rows per page: 2550 100